The Biomedical Catalyst will return later this month! In Round 1, UK registered SMEs can apply for a share of £15 million to develop innovative health or healthcare-focused products, technologies and processes.


Projects can focus on any health or healthcare challenge. They can include a range of activities, such as:

  • experimental evaluation (at laboratory scale)
  • use of in vitro and in vivo models to evaluate proof of concept or safety
  • exploring potential production mechanisms
  • prototyping
  • product development planning
  • intellectual property protection
  • a demonstration of clinical utility and effectiveness
  • a demonstration of safety and efficacy (including phase 1 and 2 clinical trials)
  • regulatory planning

As this is the Industry-led R&D stream of the Biomedical Catalyst programme, applicants must also demonstrate existing evidence of commercial and technical feasibility.


All projects must meet the following eligibility criteria:

  • have total project costs between £150,000 and £4 million, not exceeding a grant request of £2 million
  • have at least 50% of the total project costs shared by the SMEs, if collaborative
  • start before 1 December 2022 and end before 30 November 2025
  • last between 6 months and 36 months
  • carry out all project work in the UK and intend to exploit the results from or in the UK

To lead a project or work alone, your organisation must be a UK registered SME. You can work in collaboration with other organisations, including businesses of any size, academic institutions, charities, not-for-profits, public sector organisations, or research and technology organisations. They must also be registered in the UK.

More Information

Round 1 of the Biomedical Catalyst is open from 28th March until 25th May. For more information, please visit the competition page or join the online briefing event on 5th April.

RedKnight has a strong track record of securing funding for life science companies. If you would like to discuss working together, please contact us to arrange a free consultation.